Impactive Capital’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,375,125
Closed -$202M 9
2025
Q3
$202M Hold
4,375,125
9.71% 6
2025
Q2
$231M Hold
4,375,125
10.42% 5
2025
Q1
$243M Hold
4,375,125
11.14% 4
2024
Q4
$189M Hold
4,375,125
7.77% 8
2024
Q3
$224M Buy
4,375,125
+528,755
+14% +$35.4M 8.33% 7
2024
Q2
$243M Hold
3,846,370
9.46% 5
2024
Q1
$255M Buy
3,846,370
+443,045
+13% +$36M 9.63% 5
2023
Q4
$334M Buy
3,403,325
+148,153
+5% +$12.9M 13.72% 5
2023
Q3
$261M Buy
3,255,172
+754,566
+30% +$59.2M 11.64% 5
2023
Q2
$202M Buy
2,500,606
+849,567
+51% +$79.5M 8.55% 7
2023
Q1
$201M Buy
1,651,039
+1,322,042
+402% +$180M 8.14% 8
2022
Q4
$43.8M Buy
+328,997
New +$40M 2.01% 8

Other funds holding CNXC

Impactive Capital's CNXC Position: Q4 2025 in Review

Impactive Capital sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 4,375,125 shares — an estimated $202M sold.

Impactive Capital first reported a position in CNXC in Q4 2022 and held it in 12 quarters. The position peaked at $334M in Q4 2023. 336 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Impactive Capital reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Impactive Capital sold 4,375,125 Concentrix shares in Q4 2025, an estimated $202M.
  • Impactive Capital first reported a position in Concentrix in Q4 2022 and held it in 12 quarters.
  • Impactive Capital's Concentrix position peaked at $334M in Q4 2023.
  • 336 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Impactive Capital's 13F filing for Q4 2025, filed 17 Feb 2026.